If you or a loved one have taken (or affected by) Glyxambi after February 2015 please contact us today.

FREE CASE REVIEW

Glyxambi Linked to Pancreatitis and Diabetic Ketoacidosis

Glyxambi, a popular treatment option for patients with Type 2 diabetes could increase the risk of pancreatitis and diabetic ketoacidosis, two potentially deadly conditions.

If you or a loved one is currently taking Glyxambi and have experienced serious side effects as a result, you could be entitled to medical benefits and financial compensation. You may be able to obtain these benefits  by filing a personal injury lawsuit against the manufacturer of Glyxambi. Our dangerous drug injury lawyers have many years experience handling Glyxambi lawsuits.

What is Glyxambi?

Manufactured by Boehringer Ingelheim and released in February 2015, Glyxambi is a unique combination of two other Type 2 diabetes medications. It is made up of active ingredients from popular SGLT2 inhibitor, Jardiance and the active ingredient from DPP-4 inhibitor Tradjenta. Glyxambi is prescribed, along with diet and exercise for the treatment of Type 2 diabetes.

What are the risks?

Like all SGLT2 inhibitors, Glyxambi has been linked to an increased risk for the development of diabetic ketoacidosis, a serious condition in which ketones build up in the bloodstream to toxic levels. If not treated promptly, ketoacidosis can lead to swelling of the brain, coma and even death.

SIDE EFFECTS / COMPLICATIONS

Because Glyxambi is combined with DPP-4 inhibitor Tradjenta, users of Glyxambi are also at risk for other serious side effects including pancreatitis, which can be deadly. Other risks and side effects include:

  • Kidney failure
  • Kidney stones
  • Yeast infections (both men and women)
  • Severe dehydration
  • Hypoglycemia (low blood sugar)
  • Unbalanced electrolytes
  • Urinary tract infections

Glyxambi Lawsuits

The FDA issued a warning concerning the link between all SGLT2 inhibitors and the risks of diabetic ketoacidosis in May 2015. In December the FDA ordered manufacturers of all SGLT2 inhibitors to add warning labels to all SGLT2 products that warned patients about the risks for the development of ketoacidosis and urinary tract infections.

What You Can Do Now

If you or a loved one have experienced ketoacidosis, pancreatitis, kidney failure or any other issue from taking Glyxambi, you may be entitled to compensation for your injuries.

Helping the Injured has been connecting consumers with credible law firms that handle specific case areas for over 25 years. The attorneys we work with have a documented track record in understanding these drugs and the injuries associated with them. Our attorney partners work with clients on a contingency basis, which means no cost to you unless they recover damages on your behalf.

GET YOUR FREE CASE REVIEW BY TOP-RATED LAWYERS

Regardless of where you were administered Glyxambi our team of Glyxambi lawsuit attorneys can help as they serve all 50 states and Washington D.C. including: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington D.C., West Virginia and Wisconsin.

Review My Case